3514 CDRH Premarket Review Submission Cover Sheet

Premarket Notification Submission 5100(k), Subpart E

Form FDA 3514

Premarket Notification Submission 5100(k), Subpart E

OMB: 0910-0120

Document [pdf]
Download: pdf | pdf
Print

Save As...

Reset Form

DEPARTMENT OF HEALTH AND HUMAN SERVICES
FOOD AND DRUG ADMINISTRATION

CDRH PREMARKET REVIEW SUBMISSION COVER
Date of Submission

User Fee Payment ID Number

SECTION A
PMA

Form Approval
OMB No. 9010-0120
Expiration Date: May 31, 2007.
SHEET
See OMB Statement on page 5.
FDA Submission Document Number (if known)

TYPE OF SUBMISSION
PMA & HDE Supplement

PDP

510(k)

Meeting

Original Submission:

Pre-510(K) Meeting

Original Submission

Regular (180 day)

Original PDP

Premarket Report

Special

Notice of Completion

Traditional

Pre-IDE Meeting

Modular Submission

Panel Track (PMA Only)

Amendment to PDP

Special

Pre-PMA Meeting

Amendment

30-day Supplement
30-day Notice

Abbreviated (Complete
section I, Page 5)

Pre-PDP Meeting

Report
Report Amendment

135-day Supplement

Licensing Agreement

Real-time Review

Day 100 Meeting

Additional Information

Agreement Meeting

Third Party

Determination Meeting
Other (specify):

Amendment to PMA &
HDE Supplement
Other

IDE

Humanitarian Device
Exemption (HDE)

Class II Exemption Petition

Evaluation of Automatic
Class III Designation
(De Novo)

Original Submission

Original Submission

Original Submission

Original Submission

513(g)

Amendment

Amendment

Additional Information

Supplement

Supplement

Other
(describe submission):

Additional Information

Other Submission

Report
Report Amendment

Have you used or cited Standards in your submission?

SECTION B

Yes

(If Yes, please complete Section I, Page 5)

No

SUBMITTER, APPLICANT OR SPONSOR

Company / Institution Name

Establishment Registration Number (if known)

Division Name (if applicable)

Phone Number (including area code)

Street Address

FAX Number (including area code)

(
(
City

)
)

State / Province

ZIP/Postal Code

Country

Contact Name

Contact Title

SECTION C

Contact E-mail Address

APPLICATION CORRESPONDENT (e.g., consultant, if different from above)

Company / Institution Name

Division Name (if applicable)

Phone Number (including area code)

(
Street Address

(
City

)

FAX Number (including area code)

)

State / Province

ZIP/Postal Code

Country

Contact Name

Contact Title

FORM FDA 3514 (6/05)

Contact E-mail Address

PAGE 1 OF 5 PAGES
PSC Media Arts (301) 443-1090

EF

Print

Save As...

Next Page

SECTION D1

Reset Form

REASON FOR APPLICATION - PMA, PDP, OR HDE

Withdrawal
Additional or Expanded Indications

Change in design, component, or
specification:

Location change:
Manufacturer

Request for Extension

Software / Hardware

Sterilizer

Post-approval Study Protocol

Color Additive

Packager

Request for Applicant Hold

Material

Request for Removal of Applicant Hold

Specifications

Request to Remove or Add Manufacturing Site

Other (specify below)

Annual or Periodic

Process change:
Manufacturing
Sterilization
Packaging
Other (specify below)

Report Submission:
Post-approval Study

Labeling change:
Indications
Instructions

Adverse Reaction
Device Defect
Amendment

Performance
Shelf Life
Trade Name
Other (specify below)

Response to FDA correspondence:

Change in Ownership
Change in Correspondent
Change of Applicant Address

Other Reason (specify):

SECTION D2
New Device

REASON FOR APPLICATION - IDE
Change in:

Repose to FDA Letter Concerning:

New Indication

Correspondent / Applicant

Conditional Approval

Addition of Institution

Design / Device

Deemed Approved

Expansion / Extension of Study

Informed Consent

Deficient Final Report

IRB Certification

Manufacturer

Deficient Progress Report

Termination of Study

Manufacturing Process

Deficient Investigator Report

Withdrawal of Application

Protocol - Feasibility

Disapproval

Unanticipated Adverse Effect

Protocol - Other

Notification of Emergency Use

Sponsor

Request Extension of
Time to Respond to FDA

Compassionate Use Request
Treatment IDE
Continued Access

Request Meeting
Report submission:

Request Hearing

Current Investigator
Annual Progress Report
Site Waiver Report
Final

Other Reason (specify):

SECTION D3
New Device

REASON FOR SUBMISSION - 510(k)
Additional or Expanded Indications

Change in Technology

Other Reason (specify):

FORM FDA 3514 (6/05)

PAGE 2 OF 5 PAGES

Save As...

Print

Next Page

SECTION E

Reset Form

ADDITIONAL INFORMATION ON 510(K) SUBMISSIONS
Summary of, or statement concerning,
safety and effectiveness information

Product codes of devices to which substantial equivalence is claimed
1

2

3

4

5

6

7

8

510 (k) summary attached
510 (k) statement

Information on devices to which substantial equivalence is claimed (if known)
510(k) Number

Manufacturer

Trade or Proprietary or Model Name

1

1

1

2

2

2

3

3

3

4

4

4

5

5

5

6

6

6

SECTION F

PRODUCT INFORMATION - APPLICATION TO ALL APPLICATIONS

Common or usual name or classification

Model Number

Trade or Proprietary or Model Name for This Device
1

1

2

2

3

3

4

4

5

5

FDA document numbers of all prior related submissions (regardless of outcome)
1

2

3

4

5

6

7

8

9

10

11

12

Data Included in Submission
Laboratory Testing

SECTION G
Product Code

Animal Trials

Human Trials

PRODUCT CLASSIFICATION - APPLICATION TO ALL APPLICATIONS
C.F.R. Section (if applicable)

Device Class
Class I

Class II

Class III

Unclassified

Classification Panel

Indications (from labeling)

FORM FDA 3514 (6/05)

PAGE 3 OF 5 PAGES

Save As...

Print

Next Page

Reset Form

FDA Document Number (if known)
Note: Submission of this information does not affect the need to submit a 2891
or 2891a Device Establishment Registration form.

SECTION H

MANUFACTURING / PACKAGING / STERILIZATION SITES RELATING TO A SUBMISSION
FDA Establishment Registration Number

Original
Add

Delete

Manufacturer

Contract Sterilizer

Contract Manufacturer

Repackager / Relabeler

Company / Institution Name

Establishment Registration Number

Division Name (if applicable)

Phone Number (including area code)

(
Street Address

)

FAX Number (including area code)

(
City

)

State / Province

Contact Title

Contact Name

Delete

Manufacturer

Contract Sterilizer

Contract Manufacturer

Repackager / Relabeler

Company / Institution Name

Establishment Registration Number

Division Name (if applicable)

Phone Number (including area code)

(

)

Street Address

FAX Number (including area code)

City

State / Province

(

Contact Name

Add

)
ZIP/Postal Code

Contact Title

Delete

Manufacturer

Contract Sterilizer

Contract Manufacturer

Repackager / Relabeler

Company / Institution Name

Establishment Registration Number

Division Name (if applicable)

Phone Number (including area code)

(
Street Address

City

FORM FDA 3514 (6/05)

)

FAX Number (including area code)

(

Contact Name

Country

Contact E-mail Address

FDA Establishment Registration Number

Original

Country

Contact E-mail Address

FDA Establishment Registration Number

Original
Add

ZIP/Postal Code

)

State / Province

Contact Title

ZIP/Postal Code

Country

Contact E-mail Address

PAGE 4 OF 5 PAGES

Save As...

Print

Previous Page

SECTION I

Reset Form

UTILIZATION OF STANDARDS

Note: Complete this section if your application or submission cites standards or includes a "Declaration of Conformity to a Recognized Standard"
statement.
Standards No.

Standards
Organization

Standards Title

Version

Date

Standards No.

Standards
Organization

Standards Title

Version

Date

Standards No.

Standards
Organization

Standards Title

Version

Date

Standards No.

Standards
Organization

Standards Title

Version

Date

Standards No.

Standards
Organization

Standards Title

Version

Date

Standards No.

Standards
Organization

Standards Title

Version

Date

Standards No.

Standards
Organization

Standards Title

Version

Date

1

2

3

4

5

6

7

Please include any additional standards to be cited on a separate page.

Public reporting burden for this collection of information is estimated to average 0.5 hour per response, including the time for reviewing instructions, searching
existing data sources, gathering and maintaining the data needed, and completing reviewing the collection of information. Send comments regarding this burden
estimate or any other aspect of this collection of information, including suggestions for reducing this burden to:
Food and Drug Administration
CDRH (HFZ-342)
9200 Corporate Blvd.
Rockville, MD 20850
An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control

FORM FDA 3514 (6/05)

PAGE 5 OF 5 PAGES


File Typeapplication/pdf
File Modified2007-04-06
File Created2003-12-29

© 2024 OMB.report | Privacy Policy